DOI QR코드

DOI QR Code

Non-metastatic Upper Tract Transitional Cell Carcinoma: Single Center Experience

  • Demirci, Umut (Department of Medical Oncology, Ataturk Training and Research Hospital) ;
  • Canda, Abdullah Erdem (Department of Urology, Ataturk Training and Research Hospital) ;
  • Dede, Didem Sener (Department of Medical Oncology, Ataturk Training and Research Hospital) ;
  • Cakici, Ozer Ural (Department of Urology, Ataturk Training and Research Hospital) ;
  • Akinci, Muhammed Bulent (Department of Medical Oncology, Ataturk Training and Research Hospital) ;
  • Yalcin, Bulent (Department of Medical Oncology, Ataturk Training and Research Hospital)
  • Published : 2013.02.28

Abstract

Background: Upper tract transitional cell carcinomas (UTCC) are relatively uncommon but prognosis is generally worse than TCC of bladder. Methods: Between March 2004 and June 2012, patients with initial non-metastatic UTCC were assessed in the Medical Oncology and Urology Departments of Ataturk Training and Research Hospital. Results: A total of 11 patients with initially non-metastatic UTCC were detected in the 8 year period, all males. Median age of was 62 (range, 38-74). Six lesions were located in the renal pelvis and 5 in the ureter. Nephroureterectomy was performed in 9 patients, and distal ureterectomy and cuff excision of the bladder in the remaining 2. The majority (n= 9) had high grade tumors. Median primary tumor diameter was 3.5 cm (range, 0.7-10). Five patients (45.5%) were stage I, 2 (18.2%) were stage II, and 4 (36.4%) were stage III. While adjuvant chemotherapy was not applied for stage I and II disease (n= 7), 4 to 6 courses were applied for 3 of the stage III patients. Also one stage III case received adjuvant radiotherapy. Up to 100 months follow-up, median overall survival was 13 months (range, 5-100 months). While stage I and II patients are following-up without muscle-invasive progression, 2 of stage III patients demonstrated progression. Conclusion: We need more collaborative studies to determine management of especially pT3-pT4 patients with UTCC.

Keywords

References

  1. Cha EK, Shariat SF, Kormaksson M, et al (2012). Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol, 61, 818-25. https://doi.org/10.1016/j.eururo.2012.01.021
  2. Colin P, Ouzzane A, Pignot G, et al (2012). Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int, 110, 1134-41. https://doi.org/10.1111/j.1464-410X.2012.10960.x
  3. Favaretto RL, Shariat SF, Chade DC, et al (2010). The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol, 58, 574-80. https://doi.org/10.1016/j.eururo.2010.07.003
  4. Green DA, Rink M, Xylinas E, et al (2012) Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol, 12, 5012-4.
  5. Rai BP, Shelley M, Coles B, et al (2012). Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review. BJU Int, 110, 1426-35. https://doi.org/10.1111/j.1464-410X.2012.11341.x
  6. Raman JD, Ng CK, Scherr DS, et al (2010). Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol,57, 1072-9. https://doi.org/10.1016/j.eururo.2009.07.002
  7. Roupret M, Zigeuner R, Palou J, et al (2012). European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Actas Urol Esp, 36, 2-14.
  8. Slaton JW, Swanson DA, Grossman HB, Dinney CP (1999). A stage specific approach to tumour surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol, 162, 710-4 https://doi.org/10.1097/00005392-199909010-00021
  9. Yafi FA, Novara G, Shariat SF, et al (2012). Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int, 110, 7-13. https://doi.org/10.1111/j.1464-410X.2011.10792.x